Department of Physics, Ariel University, 40700, Ariel, Israel.
Department of Chemical Engineering, Ariel University, 40700, Ariel, Israel.
Sci Rep. 2023 Nov 2;13(1):18935. doi: 10.1038/s41598-023-46014-1.
Cancer is a leading cause of mortality today. Sooner a cancer is detected, the more effective is the treatment. Histopathological diagnosis continues to be the gold standard worldwide for cancer diagnosis, but the methods used are invasive, time-consuming, insensitive, and still rely to some degree on the subjective judgment of pathologists. Recent research demonstrated that Attenuated Total Reflection-Fourier Transform Infrared (ATR-FTIR) spectroscopy can be used to determine the metastatic potential of cancer cells by evaluating their membrane hydration. In the current study, we demonstrate that the conversion of ATR-FTIR spectra using multifractal transformation generates a unique number for each cell line's metastatic potential. Applying this technique to murine and human cancer cells revealed a correlation between the metastatic capacity of cancer cells within the same lineage and higher multifractal value. The multifractal spectrum value was found to be independent of the cell concentration used in the assay and unique to the tested lineage. Healthy cells exhibited a smaller multifractal spectrum value than cancer cells. Further, the technique demonstrated the ability to detect cancer progression by being sensitive to the proportional change between healthy and cancerous cells in the sample. This enables precise determination of cancer metastasis and disease progression independent of cell concentration by comparing the measured spectroscopy derived multifractal spectrum value. This quick and simple technique devoid of observer bias can transform cancer diagnosis to a great extent improving public health prognosis worldwide.
癌症是当今主要的死亡原因。癌症越早被发现,治疗效果就越好。组织病理学诊断仍然是全球癌症诊断的金标准,但所使用的方法具有侵入性、耗时、不敏感,并且仍然在一定程度上依赖病理学家的主观判断。最近的研究表明,衰减全反射-傅里叶变换红外(ATR-FTIR)光谱学可以通过评估细胞膜水合作用来确定癌细胞的转移潜力。在当前的研究中,我们证明了使用多重分形变换转换 ATR-FTIR 光谱为每个细胞系的转移潜力生成一个独特的数字。将该技术应用于鼠类和人类癌细胞,揭示了同一谱系内癌细胞的转移能力与更高的多重分形值之间存在相关性。发现多重分形谱值与测定中使用的细胞浓度无关,而是与所测试的谱系有关。健康细胞的多重分形谱值小于癌细胞。此外,该技术通过对样本中健康细胞和癌细胞之间的比例变化敏感,能够检测癌症的进展。这使得通过比较测量的光谱衍生的多重分形谱值,可以独立于细胞浓度精确确定癌症转移和疾病进展。这种快速、简单且没有观察者偏见的技术可以在很大程度上改变癌症诊断,从而改善全球公共卫生预后。